Hello and Welcome to Patientsville.com, Your Source for all KAKKONTO information. We are dedicated to provide You with KAKKONTO safety information. Learn about KAKKONTO serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
KAKKONTO Safety Reports
Total KAKKONTO reports: 2.KAKKONTO FDA safety alerts: No.
Reported hospitalizations: 2.
Take KAKKONTO Side Effects Survey or Share Your KAKKONTO Story. Read More Here.
Health Professional from JAPAN reported KAKKONTO problem on Apr 25, 2007. Male patient, weighting 169.8 lb, was diagnosed with nasopharyngitis, gastritis prophylaxis, sciatica, constipation, insomnia, diabetes mellitus, benign prostatic hyperplasia, tinea cruris and was treated with KAKKONTO. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage. KAKKONTO dosage: unknown. During the same period patient was treated with REBAMIPIDE, LIMAPROST ALFADEX, LOXOPROFEN, MAGNESIUM OXIDE, BROTIZOLAM, GLIMEPIRIDE, ALFUZOSIN, BIFONAZOLE. Patient was hospitalized. Patient recovered.
KAKKONTO problem was reported by a Health Professional from JAPAN on May 11, 2007. Male patient, weighting 169.8 lb, was diagnosed with nasopharyngitis, gastritis prophylaxis, sciatica, constipation, insomnia, diabetes mellitus, tinea cruris, hypertension and was treated with KAKKONTO. After drug was administered, patient experienced the following problems/side effects: blood pressure immeasurable, blood pressure orthostatic increased, cerebral haemorrhage, coma, hyperglycaemia. KAKKONTO dosage: unknown. During the same period patient was treated with REBAMIPIDE, LIMAPROST ALFADEX, LOXOPROFEN, MAGNESIUM OXIDE, BROTIZOLAM, GLIMEPIRIDE, BIFONAZOLE, CANDESARTAN CILEXETIL. Patient was hospitalized. Patient recovered.